Elevated local TGF-β1 level predisposes a closed bone fracture to tuberculosis infection

Medical Hypotheses

Volumn 79, Issue 3, 2012, Pages 400-402

  Li, Hao ^a   Liang, Cheng Zhen ^a   Tao, Yi Qing ^a   Shen, Cheng Chun ^a   Chen, Qi Xin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; DISEASE PREDISPOSITION; FRACTURE; FRACTURE HEALING; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; T LYMPHOCYTE; TUBERCULOSIS;

FRACTURES, BONE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; TRANSFORMING GROWTH FACTOR BETA1; TUBERCULOSIS;

EID: 84864592559     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.06.005     Document Type: Article

References (29)

1. Guo S., Xue R., Li Y., Wang S.M., Ren L., Xu J.J. The CFP10/ESAT6 complex of Mycobacterium tuberculosis may function as a regulator of macrophage cell death at different stages of tuberculosis infection. Med Hypotheses 2012, 78:389-392.
2. Mao F., Chen T., Zhao Y., Zhang C., Bai B., Zhao S., et al. Insulin resistance: a potential marker and risk factor for active tuberculosis?. Med Hypotheses 2011, 77:66-68.
3. Goldhaber-Fiebert J.D., Jeon C.Y., Cohen T., Murray M.B. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol 2011, 40:417-428.
4. Gautam M.P., Karki P., Rijal S., Singh R. Pott's spine and paraplegia. JNMA J Nepal Med Assoc 2005, 44:106-115.
5. Benzagmout M., Boujraf S., Chakour K., Chaoui Mel F. Pott's disease in children. Surg Neurol Int 2011, 2:1.
6. Huang B., Li C.Q., Zhuang Y., Xu J.P., Zhou Y. Spinal tuberculosis occurring after a closed bursting fracture of the vertebrae. Eur Spine J 2012, [Epub ahead of print].
7. Govender S., Charles R.W., Ballaram R.S., Achary D.M. Vertebral osteomyelitis after a closed fracture of the spine. A case report. S Afr Med J 1988, 73:124-126.
8. Janssens K., ten Dijke P., Janssens S., Van Hul W. Transforming growth factor-beta1 to the bone. Endocr Rev 2005, 26:743-774.
9. Matsumoto K., Matsunaga S., Imamura T., Ishidou Y., Yoshida H., Sakou T. Expression and distribution of transforming growth factor-beta and decorin during fracture healing. In Vivo 1994, 8:215-219.
10. Si X., Jin Y., Yang L., Tipoe G.L., White F.H. Expression of BMP-2 and TGF-beta 1 mRNA during healing of the rabbit mandible. Eur J Oral Sci 1997, 105:325-330.
11. Sarahrudi K., Thomas A., Mousavi M., Kaiser G., Kottstorfer J., Kecht M., et al. Elevated transforming growth factor-beta 1 (TGF-beta1) levels in human fracture healing. Injury 2011, 42:833-837.
12. Zimmermann G., Henle P., Kusswetter M., Moghaddam A., Wentzensen A., Richter W., et al. TGF-beta1 as a marker of delayed fracture healing. Bone 2005, 36:779-785.
13. Moghaddam A., Weiss S., Wolfl C.G., Schmeckenbecher K., Wentzensen A., Grutzner P.A., et al. Cigarette smoking decreases TGF-b1 serum concentrations after long bone fracture. Injury 2010, 41:1020-1025.
14. Bonecini-Almeida M.G., Ho J.L., Boechat N., Huard R.C., Chitale S., Doo H., et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 2004, 72:2628-2634.
15. Mak J.C., Leung H.C., Sham A.S., Mok T.Y., Poon Y.N., Ling S.O., et al. Genetic polymorphisms and plasma levels of transforming growth factor-beta(1) in Chinese patients with tuberculosis in Hong Kong. Cytokine 2007, 40:177-182.
16. Toossi Z., Ellner J.J. The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol 1998, 87:107-114.
17. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000, 1:169-178.
18. Patil A.S., Sable R.B., Kothari R.M. An update on transforming growth factor-beta (TGF-beta): sources, types, functions and clinical applicability for cartilage/bone healing. J Cell Physiol 2011, 226:3094-3103.
19. Kanaan R.A., Kanaan L.A. Transforming growth factor beta1, bone connection. Med Sci Monit 2006, 12:RA164-RA169.
20. Allori A.C., Sailon A.M., Warren S.M. Biological basis of bone formation, remodeling, and repair-part II: extracellular matrix. Tissue Eng Part B Rev 2008, 14:275-283.
21. Ai-Aql Z.S., Alagl A.S., Graves D.T., Gerstenfeld L.C., Einhorn T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87:107-118.
22. Estai M.A., Suhaimi F., Das S., Shuid A.N., Mohamed Z., Soelaiman I.N. Expression of TGF-beta1 in the blood during fracture repair in an estrogen-deficient rat model. Clinics (Sao Paulo) 2011, 66:2113-2119.
23. Rosier R.N., O'Keefe R.J., Hicks D.G. The potential role of transforming growth factor beta in fracture healing. Clin Orthop Relat Res 1998, S294-S300.
24. Nag H.L., Neogi D.S., Nataraj A.R., Kumar V.A., Yadav C.S., Singh U. Tubercular infection after arthroscopic anterior cruciate ligament reconstruction. Arthroscopy 2009, 25:131-136.
25. Collins H.L., Kaufmann S.H. The many faces of host responses to tuberculosis. Immunology 2001, 103:1-9.
26. Flynn J.L., Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19:93-129.
27. Hernandez-Pando R., Orozco-Esteves H., Maldonado H.A., Aguilar-Leon D., Vilchis-Landeros M.M., Mata-Espinosa D.A., et al. A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis. Clin Exp Immunol 2006, 144:264-272.
28. Hirsch C.S., Yoneda T., Averill L., Ellner J.J., Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis 1994, 170:1229-1237.
29. Musso T., Espinoza-Delgado I., Pulkki K., Gusella G.L., Longo D.L., Varesio L. Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood 1990, 76:2466-2469.